FDA 483 - Arnot Ogden Medical Center - August 14, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Arnot Ogden Medical Center's Hospital Blood Bank revealed significant deficiencies in their quality system. Observations included a lack of written standard operating procedures for investigating product deviations, inadequate equipment maintenance and calibration practices, and incomplete records for transfusion reaction investigations. These issues indicate a need for improved adherence to regulatory requirements for blood and blood component processing.
ID · af1bbfb0-d655-4ad1-bf39-a45b16980f2a